Pain
FDA/CDC
FDA okays new oral CGRP antagonist for migraine prevention
With this approval, neurologists will be able to choose from four monoclonal antibodies and two gepants for the preventive treatment of migraine...
Guidelines
Guideline gives weak support to trying oral medical cannabis for chronic pain
Does oral medical cannabis work in chronic pain? Here’s what the evidence says.
Feature
Nonopioid med promising for neuropathic pain
Top-line phase 2 data suggest vixotrigine, Biogen’s investigational oral sodium channel blocker, eases pain caused by diabetes-associated small...
Feature
As opioid deaths climb, human trials begin for vaccine
The first vaccine to enter a trial targets oxycodone.
From the Journals
Assessing headache severity via migraine symptoms can help predict outcomes
“Our hope is that this work serves as foundational basis for better understanding the complexity of headache as a symptom-based condition.”
News from the FDA/CDC
EDs saw more benzodiazepine overdoses, but fewer patients overall, in 2020
Fentanyl became increasingly involved in benzodiazepine overdose deaths through the first half of the year.
Latest News
PA gets prison time for knowingly prescribing unneeded addictive drugs
The PA also admitted that in several instances he engaged in sexual, physical contact with female patients who were attempting to get...
From the Journals
Atogepant reduces migraine days: ADVANCE trial results published
“Overall, this study showed us that atogepant was safe and surprisingly seems to be pretty effective regardless of the dose.”
Latest News
Doctor wins restraining order against CVS after prescription ban
A judge ruled that the doctor is likely to succeed in his claim that CVS barred his prescriptions without evidence that he violated any law or...
Latest News
Physician ‘predator’ sentenced for opioid-related patient death; more
“Doctors take an oath to first do no harm, and instead, Ballard chose to put his own licentious interests above his patients’ well-being.”
From the Journals
Occipital nerve stimulation offers relief for patients with intractable chronic cluster headache
The frequency of attacks may decrease with neuromodulation intervention, a new trial suggests.